Holl R - Search Results

1

Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies.

Dreger A, Hoff K, Agoglitta O, Hotop SK, Brönstrup M, Heisig P, Kirchmair J, Holl R. Dreger A, et al. Among authors: holl r. Bioorg Chem. 2021 Feb;107:104603. doi: 10.1016/j.bioorg.2020.104603. Epub 2020 Dec 31. Bioorg Chem. 2021. PMID: 33429229

2

Synthesis and biological evaluation of flexible and conformationally constrained LpxC inhibitors.

Löppenberg M, Müller H, Pulina C, Oddo A, Teese M, Jose J, Holl R. Löppenberg M, et al. Among authors: holl r. Org Biomol Chem. 2013 Sep 28;11(36):6056-70. doi: 10.1039/c3ob41082j. Org Biomol Chem. 2013. PMID: 23917427

3

Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.

Szermerski M, Melesina J, Wichapong K, Löppenberg M, Jose J, Sippl W, Holl R. Szermerski M, et al. Among authors: holl r. Bioorg Med Chem. 2014 Feb 1;22(3):1016-28. doi: 10.1016/j.bmc.2013.12.057. Epub 2014 Jan 3. Bioorg Med Chem. 2014. PMID: 24412340

4

Synthesis and biological evaluation of enantiomerically pure glyceric acid derivatives as LpxC inhibitors.

Tangherlini G, Torregrossa T, Agoglitta O, Köhler J, Melesina J, Sippl W, Holl R. Tangherlini G, et al. Among authors: holl r. Bioorg Med Chem. 2016 Mar 1;24(5):1032-44. doi: 10.1016/j.bmc.2016.01.029. Epub 2016 Jan 18. Bioorg Med Chem. 2016. PMID: 26827141

5

Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitors.

Müller H, Gabrielli V, Agoglitta O, Holl R. Müller H, et al. Among authors: holl r. Eur J Med Chem. 2016 Mar 3;110:340-75. doi: 10.1016/j.ejmech.2016.01.032. Epub 2016 Jan 20. Eur J Med Chem. 2016. PMID: 26866455

6

Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.

Kalinin DV, Wagner S, Riemann B, Hermann S, Schmidt F, Becker-Pauly C, Rose-John S, Schäfers M, Holl R. Kalinin DV, et al. Among authors: holl r. J Med Chem. 2016 Oct 27;59(20):9541-9559. doi: 10.1021/acs.jmedchem.6b01291. Epub 2016 Oct 13. J Med Chem. 2016. PMID: 27696839

7

LpxC inhibitors: a patent review (2010-2016).

Kalinin DV, Holl R. Kalinin DV, et al. Among authors: holl r. Expert Opin Ther Pat. 2017 Nov;27(11):1227-1250. doi: 10.1080/13543776.2017.1360282. Epub 2017 Aug 4. Expert Opin Ther Pat. 2017. PMID: 28742403 Review.

8

Chiral Pool Synthesis, Biological Evaluation and Molecular Docking Studies of C-Furanosidic LpxC Inhibitors.

Dreger A, Kharwb O, Agoglitta O, Bülbül EF, Melesina J, Sippl W, Holl R. Dreger A, et al. Among authors: holl r. ChemMedChem. 2019 Apr 17;14(8):871-886. doi: 10.1002/cmdc.201900068. Epub 2019 Mar 12. ChemMedChem. 2019. PMID: 30801965

9

Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies.

Kalinin DV, Agoglitta O, Van de Vyver H, Melesina J, Wagner S, Riemann B, Schäfers M, Sippl W, Löffler B, Holl R. Kalinin DV, et al. Among authors: holl r. Bioorg Med Chem. 2019 May 15;27(10):1997-2018. doi: 10.1016/j.bmc.2019.03.056. Epub 2019 Mar 30. Bioorg Med Chem. 2019. PMID: 30954331

10

Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 Inhibitors.

Kalinin DV, Jana SK, Pfafenrot M, Chakrabarti A, Melesina J, Shaik TB, Lancelot J, Pierce RJ, Sippl W, Romier C, Jung M, Holl R. Kalinin DV, et al. Among authors: holl r. ChemMedChem. 2020 Apr 3;15(7):571-584. doi: 10.1002/cmdc.201900583. Epub 2020 Jan 9. ChemMedChem. 2020. PMID: 31816172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters